Skip directly to search Skip directly to A to Z list Skip directly to site content
CDC Home

Guideline for the Prevention and Control of Norovirus Gastroenteritis Outbreaks in Healthcare Settings, 2011

Evidence Table Q3 - Medications

Author, Yr (Ref) Study Design Quality Study Objective Population and Setting N Results Comments Ref ID_Data extracted by

Rossignol, JF; 2006 202

Randomized Controlled Trial

1,3,5,7,9

To evaluate nitazoxanide 500mg vs placebo given to adults or adolescents twice daily for 3 days for the resolution of symptoms due to viral gastroenteritis.

Patients at least 12 years of age with gastroenteritis presenting to outpatient clinics at a university hospital in Egypt.

50 outpatients.

Symptoms
Nausea in patients with norovirus vs other viral infections – 6/13 (46%) vs 1/32 (3%); p=0.0013

Time from first dose to symptom resolution
All results nitazoxanide vs placebo in days (IQR); p value
Overall – 1.5 (0.5-2.5) vs 2.5 (1.5-4.5); <0.0001
For Rotavirus infection – 1.5 (0.5-1.5) vs 2.5 (1.5->6.5);0.0052
For norovirus infection – 1.5 (1.5-1.5) vs 2.5 (1.5-6.5); 0.0295

Patients with diarrhea (≥3 diarrheal stools per day) and stool-positive for rotavirus, norovirus, or adenovirus were eligible for enrollment.

Outcome was resolution for at least 72 hours of all symptoms of viral gastroenteritis that were present at enrollment.

A sample size of 19 patients per group, with a 0.05 level two-sided log-rank test for equality of survival curves, had 80% power to detect a difference between an 85% response rate for 1 group and a 40% response rate for a second group at a given time. A sample size of 25 patients per group allowed for exclusion of up to 20% due to other identified causes of diarrhea.

212_IL

Gustafson, TL; 1983 203

Retrospective controlled study

1,2,3,4

To determine whether certain medications protected patients from symptomatic disease during a norovirus outbreak.

Patients and staff in a chronic-care hospital in Tennessee.

Cases – 22 employees and 31 patients.

Controls – 14 employees and 25 patients.

Cases
55% of elderly psychiatric patients and 61% of nursing employees.

Protective medications
Attack rates; p values
Patients only on antipsychotic drugs vs on antipsychotic drugs plus trihexyphenidyl or benztropine – 71% vs 14%; 0.013

Patients on psyllium hydrophilic mucilloid vs not receiving psyllium: 27% vs 71%; 0.012

Two case definitions used:
For hospital personnel –  any person with vomiting or diarrhea (≥1 liquid stools/ day), or two of the following symptoms (abdominal pain, abdominal cramps, or nausea).
For patients – any patient with vomiting or diarrhea.

Power and sample size not reported.

2014_IL

 

Next Table

 
USA.gov: The U.S. Government's Official Web PortalDepartment of Health and Human Services
Centers for Disease Control and Prevention   1600 Clifton Rd. Atlanta, GA 30333, USA
800-CDC-INFO (800-232-4636) TTY: (888) 232-6348 - Contact CDC–INFO
A-Z Index
  1. A
  2. B
  3. C
  4. D
  5. E
  6. F
  7. G
  8. H
  9. I
  10. J
  11. K
  12. L
  13. M
  14. N
  15. O
  16. P
  17. Q
  18. R
  19. S
  20. T
  21. U
  22. V
  23. W
  24. X
  25. Y
  26. Z
  27. #